Philip Morris International reported Q2 results on July 22 and gave back ground, falling 2.4% on the day to $188.04 — yet the full-week picture remains firmly positive, with the stock up nearly 7% from Monday's open, continuing the strong run flagged in the pre-earnings note published earlier this week.
The post-earnings pullback did not disturb the borrow market at all. Availability remains extraordinarily loose — over 9,999% by ORTEX measure, implying more than a billion shares sit available against fewer than 18 million currently borrowed. Cost to borrow ticked up 31% on the week to 0.48%, but in absolute terms that is negligible. Short interest at 1.1% of the free float is structurally irrelevant as a pressure source. What shifted slightly is options sentiment: the put/call ratio eased to 1.13, just below its 20-day average of 1.15, suggesting that the pre-earnings hedging demand flagged in Tuesday's note has started to bleed off now that the print is behind us. The z-score at -0.65 points to positioning that is actually a touch less defensive than recent norms — a mild reversal from the cautious stance heading into results.
The Street comes out of earnings with a modestly split picture. The most recent target revision on record has UBS maintaining its Neutral at $182, raised from $168 in early July — still well below the current price. Morgan Stanley, meanwhile, kept its Overweight and lifted to $200 back in June, and Needham has held a $200 Buy for months. The consensus mean target of $194.86 implies limited upside from $188, which partly explains why the stock pulled back after a strong run into the print. The central tension the Street is pricing is unchanged: accelerating smoke-free volumes from IQOS and ZYN against a structurally declining combustibles base and near-term pressure from Japanese excise tax changes. The forward earnings yield factor scores rank only in the 26th percentile for 12-month EPS growth — bears can legitimately point to a stock that has re-rated sharply on transition momentum while underlying earnings-per-share growth remains under pressure. The dividend score, by contrast, ranks in the 97th percentile, underscoring why income-focused holders are content to stay long regardless of near-term EPS noise.
The institutional base offers another layer of stability. Capital Research alone holds 18.5% of shares — an anchor position that damps volatility. BlackRock and State Street together add another 10%, and JP Morgan Asset Management added over 7 million shares in the most recent reported period. The weight of passive and long-only ownership here is substantial enough that any short-driven move would face considerable natural buying interest. The ORTEX short score of 32.1 has been essentially flat all week, consistent with a stock where shorts are neither building conviction nor covering in size.
The one reading worth watching from here is the earnings reaction itself. The most recent prior earnings event in this dataset — the May print — generated a +1.0% next-day move and a +10.9% five-day move, a notably strong tail that helped fuel the run into this week's results. Whether Tuesday's Q2 print produces a similar multi-day drift or fades faster will clarify whether the market is still willing to pay for the smoke-free narrative at current multiples, with the PE at 21.4x and EV/EBITDA compressing slightly over the past month. The next scheduled earnings event falls in late October — the Q3 print is the next hard catalyst on the calendar.
See the live data behind this article on ORTEX.
Open PM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
